Enhancing neurite growth and neural functions on polymeric nerve conduit with BMSC-derived ECM coating.

Miaoben Wu, Haiyang Wang, Kailei Xu, Jin Mei, Zonghuan Wang
{"title":"Enhancing neurite growth and neural functions on polymeric nerve conduit with BMSC-derived ECM coating.","authors":"Miaoben Wu, Haiyang Wang, Kailei Xu, Jin Mei, Zonghuan Wang","doi":"10.1088/1748-605X/ad6ac0","DOIUrl":null,"url":null,"abstract":"<p><p>The therapy of large defects in peripheral nerve injury (PNI) suffers from several drawbacks, especially the lack of autologous nerve donors. Nerve conduits are considered as a solution for nerve injury treatment, but biocompatibility improvements is still required for conduits prepared with synthetic materials. Cell-derived extracellular matrix (ECM) has drawn attention due to its lower risk of immunogenic response and independence from donor availability. The goal of this study is to coat bone mesenchymal stem cell-derived ECMs on poly(lactic-co-glycolic) acid (PLGA) conduits to enhance their ability to support neural growth and neurite extensions. The ECM-coated conduits have better hydrophilic properties than the pure PLGA conduits. A marked increase on PC12 and RSC96 cells' viability, proliferation and dorsal root ganglion neurite extension was observed. Quantitative PCR analysis exhibited a significant increase in markers for cell proliferation (GAP43), neurite extension (NF-H, MAP2, and<i>β</i>III-tubulin) and neural function (TREK-1). These results show the potential of ECM-coated PLGA conduits in PNI therapy.</p>","PeriodicalId":72389,"journal":{"name":"Biomedical materials (Bristol, England)","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomedical materials (Bristol, England)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1088/1748-605X/ad6ac0","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The therapy of large defects in peripheral nerve injury (PNI) suffers from several drawbacks, especially the lack of autologous nerve donors. Nerve conduits are considered as a solution for nerve injury treatment, but biocompatibility improvements is still required for conduits prepared with synthetic materials. Cell-derived extracellular matrix (ECM) has drawn attention due to its lower risk of immunogenic response and independence from donor availability. The goal of this study is to coat bone mesenchymal stem cell-derived ECMs on poly(lactic-co-glycolic) acid (PLGA) conduits to enhance their ability to support neural growth and neurite extensions. The ECM-coated conduits have better hydrophilic properties than the pure PLGA conduits. A marked increase on PC12 and RSC96 cells' viability, proliferation and dorsal root ganglion neurite extension was observed. Quantitative PCR analysis exhibited a significant increase in markers for cell proliferation (GAP43), neurite extension (NF-H, MAP2, andβIII-tubulin) and neural function (TREK-1). These results show the potential of ECM-coated PLGA conduits in PNI therapy.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
用 BMSC 衍生的 ECM 涂层增强聚合物神经导管上的神经元生长和神经功能。
治疗周围神经损伤(PNI)的大面积缺损有几个缺点,尤其是缺乏自体神经供体。神经导管被认为是神经损伤治疗的一种解决方案,但使用合成材料制备的导管仍需改善生物相容性。细胞衍生的细胞外基质(ECM)因其免疫原反应风险较低且不受供体可用性的限制而备受关注。本研究的目的是将骨间充质干细胞(BMSC)衍生的 ECM 涂覆在聚(乳酸-共聚乙醇)酸(PLGA)导管上,以增强其支持神经生长和神经元延伸的能力。与纯聚乳酸导管相比,涂有 ECM 的导管具有更好的亲水性。PC12 和 RSC96 细胞的存活率、增殖和背根神经节神经元延伸明显增加。定量 PCR 分析表明,细胞增殖(GAP43)、神经元延伸(NF-H、MAP2 和 βIII-tubulin)和神经功能(TREK-1)的标记物明显增加。这些结果表明,ECM 包裹的 PLGA 导管具有治疗 PNI 的潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Osteogenesis promotion on MC3T3 by micro-area potential difference (MAPD) on titanium alloy. An aligned pattern sponge based on gelatin for rapid hemostasis. 3D printedβ-TCP scaffolds loaded with SVVYGLR peptide for promoting revascularization and osteoinduction. Biomaterials for bone tissue engineering: achievements to date and future directions. Inhibition of hepatocellular carcinoma progression by methotrexate-modified pH-sensitive sorafenib and Schisandrin B micelles.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1